Systemic coagulation parameters in mice after treatment with vascular targeting agents

BACKGROUND: Vascular targeting of malignant tumors has become a clinically validated new treatment approach with clear patient benefit. However clinical studies have also revealed that some types of vascular targeting agents (VTAs) are prone to coagulation system side effects. It is therefore essent...

Descripción completa

Detalles Bibliográficos
Autores principales: Unruh, Maike, Grunow, Andrea, Gottstein, Claudia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Original Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1343590/
https://www.ncbi.nlm.nih.gov/pubmed/16336690
http://dx.doi.org/10.1186/1477-9560-3-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1343590/
https://www.ncbi.nlm.nih.gov/pubmed/16336690
http://dx.doi.org/10.1186/1477-9560-3-21

Ejemplares similares